Zimbabwe has turned down a significant American healthcare agreement worth $367m (£272m) over five years over Washington's request for sensitive biological samples.
This move was revealed following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official representative has since clarified that the United States was demanding access to health data for scientific study and commercial purposes but was not willing to guarantee the benefits from future treatments.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to find a deal acceptable to all parties so the country's vital HIV programme can be sustained.
Wider Implications
This development follows a comparable situation in Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance openness and accountability.
As per statements, 16 nations in Africa have so far signed these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be available to our population if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of one-on-one deals were undermining frameworks previously established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This framework is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how future collaboration might be arranged in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts said it understood the government's concerns, but urged that talks need to persist considering a large portion of the country's HIV programmes relied on foreign aid.
"In cases where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it added.
This impasse emphasises the continuing tensions between receiving vital foreign assistance and safeguarding a country's data in an increasingly interconnected world.